Susquehanna International Group’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$250K Buy
84,900
+50,700
+148% +$225K ﹤0.01% 11271
2025
Q4
$170K Sell
34,200
-37,900
-53% -$165K ﹤0.01% 11049
2025
Q3
$227K Buy
72,100
+61,500
+580% +$169K ﹤0.01% 10719
2025
Q2
$24K Buy
+10,600
New +$30.2K ﹤0.01% 12302
2025
Q1
Sell
-87,100
Closed -$307K 12368
2024
Q4
$307K Buy
87,100
+19,200
+28% +$87K ﹤0.01% 9787
2024
Q3
$322K Sell
67,900
-58,100
-46% -$265K ﹤0.01% 9452
2024
Q2
$592K Sell
126,000
-50,600
-29% -$244K ﹤0.01% 7861
2024
Q1
$804K Buy
176,600
+148,700
+533% +$660K ﹤0.01% 7399
2023
Q4
$115K Buy
+27,900
New +$122K ﹤0.01% 11214
2023
Q3
Sell
-50,900
Closed -$264K 11919
2023
Q2
$264K Sell
50,900
-18,000
-26% -$126K ﹤0.01% 9702
2023
Q1
$469K Buy
+68,900
New +$327K ﹤0.01% 8719
2022
Q3
Sell
-15,200
Closed -$74K 13060
2022
Q2
$74K Sell
15,200
-21,400
-58% -$145K ﹤0.01% 11725
2022
Q1
$277K Buy
36,600
+16,100
+79% +$120K ﹤0.01% 10465
2021
Q4
$159K Buy
+20,500
New +$161K ﹤0.01% 11723
2015
Q3
Sell
-11
Closed -$58K 9569
2015
Q2
$58K Buy
11
+3
+38% +$14.9K ﹤0.01% 9843
2015
Q1
$38K Hold
8
﹤0.01% 9195
2014
Q4
$39K Sell
8
-15
-65% -$73.3K ﹤0.01% 9406
2014
Q3
$135K Sell
23
-21
-48% -$146K ﹤0.01% 8953
2014
Q2
$359K Sell
44
-13
-23% -$160K ﹤0.01% 8081
2014
Q1
$1.48M Buy
+57
New +$1.4M ﹤0.01% 4820
2013
Q3
Sell
-8
Closed -$162K 8343
2013
Q2
$162K Buy
+8
New +$179K ﹤0.01% 7580

Other funds holding ACHV

Susquehanna International Group's ACHV Position: Q1 2026 in Review

Susquehanna International Group reduced its Achieve Life Sciences (ACHV) stake by 23% in Q1 2026, selling an estimated $500K and leaving 383,683 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #7566.

Susquehanna International Group first reported a position in ACHV in Q4 2013 and has held it in 30 quarters since. The position peaked at $2.47M in Q4 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

  • Susquehanna International Group held 383,683 shares of Achieve Life Sciences worth $1.13M as of Q1 2026.
  • Susquehanna International Group sold 112,667 Achieve Life Sciences shares in Q1 2026, an estimated $500K.
  • Achieve Life Sciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7566 holding.
  • Susquehanna International Group first reported a position in Achieve Life Sciences in Q4 2013 and has held it in 30 quarters since.
  • Susquehanna International Group's Achieve Life Sciences position peaked at $2.47M in Q4 2025.
  • 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.